Vulvar Vestibulitis Clinical Trial
Official title:
"Vestibulitis Educational Seminar Trial" Study
The purpose of this study is to investigate the efficacy of an educational seminar series for women with vulvar vestibulitis syndrome (VVS).
HYPOTHESIS: It is hypothesized that this educational seminar series might be effective in
reducing the pain experienced and improving sexual response and quality of life of women
with Vulvar Vestibulitis Syndrome (VVS) by providing an open forum for discussion of the
pathology, etiological theories, treatment plans as well as the impact of sexual pain on
sexual relationships and ways to cope with VVS.
At Vancouver Hospital, the current waitlist for women with distressing, unremitting genital
pain is approximately 10 months. Once accepted for management, the diagnosis of VVS is
given, where applicable, by Dr. Sadownik. Only women with pure VVS and without a compounding
skin condition are then referred on to the 3-session educational seminars given by Dr.
Thomson. By the end of the educational series, women have an understanding of current
scientific literature on etiology and treatment of VVS, and it's interaction with sexual
health factors. At this point they are referred for individualized treatment of the VVS
either by Dr. Thomson, Dr. Sadownik or back to their referring physician. This study aims to
explore the existing VVS Educational Seminars by measuring sexual function, sexual distress,
pain levels (general pain, genital pain and pain upon sexual activity), psychological
well-being (depression and anxiety), relationship satisfaction, sexual knowledge and overall
quality of life at pre- and post seminar. An age-matched control group of women diagnosed
with VVS, but unable to attend the Seminar series, will complete the measures at the same
intervals as the treatment group. The use of the control group allows us to accurately
evaluate the efficacy of the Educational seminars, above and beyond non-specific factors.
Vulvar Vestibulitis Syndrome Educational Seminars have been run through the Vulvar Disease
Clinic at Vancouver Hospital since 2001, however no data has been collected to determine the
effects of this program. By collecting pre- & post seminar and follow up data, this study
will allow us to assess the efficacy of the VVS Educational Seminars when compared to a
group of women suffering from VVS but unable to attend the information seminars. Given that
a large proportion of the women cannot be treated at Vancouver Hospital and are instead
referred back to their family physician, the VVS Educational Seminar is a necessary first
step in the treatment process for ensuring that women receive accurate and timely treatment.
It will also help treatment providers improve and expand their current treatment practices
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05478746 -
Effects of Flourish HEC on Localized Provoked Vulvodynia
|
N/A | |
Completed |
NCT02494934 -
Effectiveness of Cognitive Behavioural Therapy and Physical Therapy for Provoked Vestibulodynia
|
N/A | |
Completed |
NCT01996384 -
Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study
|
Phase 1 | |
Completed |
NCT00501774 -
A Search for Helicobacter Pylori in Localized Vulvodynia
|
N/A | |
Not yet recruiting |
NCT02393911 -
Dysbiosis in Localized Provoked Vulvodynia (LPV)
|
Phase 3 | |
Completed |
NCT02204319 -
Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief
|
N/A | |
Recruiting |
NCT03481621 -
Effect of Two Acupuncture Protocols on Vulvodynia
|
N/A | |
Completed |
NCT02704234 -
Acupuncture for Vulvodynia: A Pre-pilot Study
|
N/A | |
Completed |
NCT03364127 -
Effect of Acupuncture on Patient Vulvodynia Outcomes
|
N/A | |
Completed |
NCT02197429 -
Acupuncture for the Treatment of Vulvodynia
|
N/A | |
Terminated |
NCT00853229 -
Pregabalin for the Treatment of Vulvodynia
|
Phase 2 | |
Terminated |
NCT00450242 -
5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
|
Phase 2 | |
Recruiting |
NCT00119886 -
Botox on Vulvar Vestibulitis
|
Phase 4 |